I am an investor

Read more

I want to know more about Cantargia's research

Read more

I want to know more about Cantargia as a company

Read more

Presentation at ASCO 2019, follow up articles and interviews

Read more

Cantargia interview at EFN after ASCO

To the interview (in Swedish)

Cantargia partners up with pioneer within biotech industry

Read more

A brief introduction to Cantargia

To the interview

Two Nobel Prizes with utmost significance for Cantargia’s research

Read more

”During 2018, we concluded the first very important part of the clinical development of CAN04 and presented patient data that strengthens our hopes that CAN04 can become an important part of tomorrow’s cancer treatment”


Göran Forsberg
CEO Cantargia